Kwonoh Park, Inkeun Park, Jae Lyun Lee. "A randomized phase 3 trial of docetaxel added to ADT plus ARTA in patients with metastatic hormone-sensitive prostate cancer (Adding Docetaxel, KCSG- GU22-24).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps276